← Back to headlines
PTC Therapeutics Targets Significant Revenue Growth by 2026
PTC Therapeutics has outlined a target of 19%-36% product revenue growth by 2026, driven by accelerating global momentum for its Sephience product.
20 Feb, 18:25 — 20 Feb, 18:25
Read at source (1 outlet)
Related Stories
Top Coal and Consumable Fuels Stocks by Year-To-Date Performance
4m ago
Century Aluminum Targets 630,000-Ton Shipment by 2026 with Smelter and Expansion Progress
4m ago
United Airlines Overhauls Loyalty Program to Reward Cardholders
4m ago
ScotRail to Introduce £10 Minimum Fare for Ticketless Passengers
4m ago